FDA Drug Application (075390) for NAPROXEN by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number075390
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROXEN
Active IngredientNAPROXEN

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by MYLAN PHARMS INC